Alivira acquires Cadila’s animal health biz in Germany
25 April 2018 | News
Alivira Animal Health, through Alivira Ireland, has bought Bremer Pharma GmbH from Cadila for an enterprise value of 2.26 million euros.
Image credit- videoblocks.com
Mumbai-based pharmaceutical company SeQuent Scientific's subsidiary Alivira Animal Health Ltd has acquired 100 per cent stake in Cadila Healthcare’s animal health business in Germany.
Alivira Animal Health, through Alivira Ireland, has bought Bremer Pharma GmbH from Cadila for an enterprise value of 2.26 million euros ($2.8 million).
Founded in 1982, Bremer Pharma is a veterinary health company in Germany which focuses on the cattle and swine segments. It has an injectable manufacturing facility.
This acquisition provides Alivira's with a beta-lactam & non-beta lactam injectables facility for EU markets, which compliments its Orals & Powders beta-lactam and non-beta lactam facility based at Barcelona in Spain. EU is Alivira's largest market accounting to 60 per cent of revenues.
